These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 620345)

  • 1. Stimulation of dopamine release by GABA in rat striatal slices.
    Giorguieff MF; Kemel ML; Glowinski J; Besson MJ
    Brain Res; 1978 Jan; 139(1):115-30. PubMed ID: 620345
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for an intrastriatal GABA-ergic influence on dopamine neurones of the cat.
    Bartholini G; Stadler H
    Neuropharmacology; 1977 May; 16(5):343-7. PubMed ID: 865661
    [No Abstract]   [Full Text] [Related]  

  • 3. GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum.
    Starr MS
    Eur J Pharmacol; 1978 Apr; 48(3):325-8. PubMed ID: 639860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of GABA in dyskinesias induced by chemical stimulation of the striatum.
    Standefer MJ; Dill RE
    Life Sci; 1977 Nov; 21(10):1515-20. PubMed ID: 927013
    [No Abstract]   [Full Text] [Related]  

  • 5. GABA enhancement of [3H]dopamine release from slices of rat striatum: dependence on slice size.
    Ennis C; Cox B
    Eur J Pharmacol; 1981 Mar; 70(3):417-20. PubMed ID: 7227457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attempts to localize the GABA receptors involved in the GABA-induced release of newly-synthesized [3H]dopamine in rat striatal slices.
    Giorguieff-Chesselet MF; Kemel ML; Wandscheer D; Glowinski J
    Brain Res; 1979 Oct; 175(2):383-6. PubMed ID: 226228
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of GABAergic drugs on dopamine catabolism in the nigrostriatal and mesolimbic dopaminergic pathways of the rat.
    Gundlach AL; Beart PM
    J Pharm Pharmacol; 1981 Jan; 33(1):41-3. PubMed ID: 6114152
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of some neurotransmitters on the release of dopamine in rat striatal slices.
    Besson MJ; Kemel ML; Glowinski J; Gioguieff MF
    Appl Neurophysiol; 1979; 42(1-2):72-4. PubMed ID: 36838
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the effects of GABA and glycine on the release of [3H]-dopamine from rat striatal slices [proceedings].
    Kerwin RW; Pycock CJ
    Br J Pharmacol; 1979 May; 66(1):106P. PubMed ID: 454901
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine may influence striatal GABA release via three separate mechanisms.
    Bernath S; Zigmond MJ
    Brain Res; 1989 Jan; 476(2):373-6. PubMed ID: 2649207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of avermectin B1a and picrotoxin on striatal release of dopamine with reference to replacement of extracellular chloride with nitrate.
    Ishiko J; Inagaki C; Takaori S
    Neuropharmacology; 1985 Dec; 24(12):1147-54. PubMed ID: 4094651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre- and postsynaptic striatal dopamine receptors: differential sensitivity to apomorphine inhibition of [3H]dopamine and [14C]GABA release in vitro.
    Brase DA
    J Pharm Pharmacol; 1980 Jun; 32(6):432-3. PubMed ID: 6106680
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycine stimulates the spontaneous release of newly synthesized 3H-dopamine in rat striatal slices.
    Giorguieff-Chesselet MF; Kemel ML; Wandscheer D; Glowinski J
    Eur J Pharmacol; 1979 Nov; 60(1):10U-4. PubMed ID: 520411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased dopamine release from rat striatal slices by inhibitors of GABA-aminotransferase.
    Stoof JC; Mulder AH
    Eur J Pharmacol; 1977 Nov; 46(2):177-80. PubMed ID: 590329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabaergic processes involved in the control of dopamine release from nigrostriatal dopaminergic neurons in the cat.
    Chéramy A; Nieoullon A; Glowinski J
    Eur J Pharmacol; 1978 Apr; 48(3):281-95. PubMed ID: 639856
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U
    Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons.
    Seeman P; Lee T
    Science; 1975 Jun; 188(4194):1217-9. PubMed ID: 1145194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aminooxyacetic acid and baclofen on the catalepsy and on the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats.
    Kääriäinen I
    Acta Pharmacol Toxicol (Copenh); 1976 Sep; 39(3):393-400. PubMed ID: 989685
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical effects of baclofen (beta-parachlorophenyl-GABA) on the dopamine and the noradrenaline in the rat brain.
    Andén NE; Wachtel H
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):310-20. PubMed ID: 576560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of taurine, GABA and dopamine from rat striatal slices: mutual interactions and developmental aspects.
    Kontro P; Oja SS
    Neuroscience; 1988 Jan; 24(1):49-58. PubMed ID: 3368056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.